Cameco Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CCJ research report →
Range $97 – $175
Price Chart
About the company
Cameco Corporation is a prominent global enterprise specializing in the production and distribution of uranium. Its operations are structured into two core divisions: Uranium and Fuel Services. The Uranium division manages the full upstream process, encompassing the exploration, extraction, and initial processing (milling) of uranium ore, as well as the procurement and sale of uranium concentrate.
- CEO
- Timothy S. Gitzel
- IPO
- 1996
- Employees
- 3,082
- HQ
- Saskatoon, SK, CA
AI snapshot
Six angles, distilled from the data.
The stock is still in a corrective phase after a strong run, trading below its 200-day average and well off the 52-week high. That keeps the longer-term trend cautious, even though the share price remains above the 52-week low and the beta near 1.0 points to market-like volatility.
Street sentiment stays constructive: consensus is Buy, with 13 Buys, 5 Holds, and 2 Sells. The average target sits at 126.74, well above the current level, though recent target moves have been mixed, including fresh initiation at Jefferies and a lower target from Barclays.
The earnings backdrop is uneven but still workable. Cameco has beaten in 4 of the last 7 reported quarters, while the next-year EPS view rises to 2.5888 from a 0.57 TTM base, so shareholders should watch for execution on uranium pricing, fuel services, and Westinghouse contribution.
No notable insider buying or selling in recent quarters. With no reported transactions, there is no discretionary signal to read into from management activity.
Profitability is modest but positive, with a 35.1% gross margin, 9.11% operating margin, and 10.21% net margin. Growth has been soft recently, with revenue down 7.2% year over year and earnings down 92.1%, but free cash flow remains strong at 1.74 billion and the balance sheet shows net cash of 191.4 million.
Cameco stands out as a pure uranium and nuclear-fuel platform with added reactor-services exposure through Westinghouse. The valuation is rich at 68.01 times earnings, so the setup favors investors who are paying for long-duration nuclear demand rather than near-term multiple support.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $38.10B
- P/E
- 152.65
- Fwd P/E
- 59.40
- PEG
- -4.58
- P/S
- 15.64
- P/B
- 7.62
- EV/EBITDA
- 62.91
- Div Yield
- 0.19%
- Gross Margin
- 27.57%
- Op Margin
- 14.26%
- Net Margin
- 10.21%
- ROE
- 5.09%
- ROIC
- 3.93%
Latest fiscal year · YoY change
- Revenue
- $3.48B+10.9%
- Gross Profit
- $929.85M-12.5%
- Op Income
- $580.42M
- Net Income
- $589.10M+242.8%
- EPS
- $1.35+237.5%
- OCF Growth
- +55.6%
- FCF Growth
- +55.0%
- 52W High
- $135.24
- 52W Low
- $77.70
- 50D MA
- $94.62
- 200D MA
- $105.66
- Beta
- 1.06
- RSI (14)
- 39
- Avg Volume
- 3.19M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Cameco said Q2 results were softer than last year due mainly to a large Westinghouse Dukovany-related benefit in 2025, but it remained on track for 2026 as uranium markets strengthened and Westinghouse’s AP1000 pipeline expanded.· July 31, 2026
- Uranium and fuel markets kept improving, with long-term uranium pricing at decade highs and more contracting activity.
- 2026 production guidance was unchanged at 19.5 million to 21.5 million pounds of U3O8 for Cameco’s share.
- Q2 financials were lower than last year largely because 2025 included a significant Westinghouse Dukovany payment.
- Cameco said it stayed disciplined on contracting and has more than 28 million pounds per year contracted on average over the next 5 years.
- Westinghouse disclosed more detail on a 91-reactor AP1000 pipeline, long-lead-item financing, and future growth options such as AP300 and eVinci.
Cameco said second-quarter 2026 financial results were lower than the strong second quarter and first half of 2025, largely because 2025 included a significant Westinghouse contribution tied to the Dukovany reactor construction project in the Czech Republic. Average realized prices continued to improve in both uranium and fuel services, and the annual production outlook was unchanged. Cameco reiterated 2026 share of production of 19.5 million to 21.5 million pounds of U3O8. Management said the company remains on track for the year, but some outlook metrics changed because a stronger U.S. dollar drove a change in the exchange-rate assumption. No revenue, EPS, or gross margin figures were stated in the transcript.
Tim Gitzel framed the quarter as consistent with Cameco’s long-term strategy and said the company is on track with expectations for the year. He stressed that nuclear energy support is becoming more tangible globally, citing policy support in Canada and the U.S. and saying the industry is moving from ambition to execution. His tone was constructive and disciplined: Cameco will keep being selective on contracting, protect downside, and avoid committing supply at prices that do not reflect stronger fundamentals.
Heidi Shockey addressed the one specific financial driver discussed in detail: the higher cost outlook was mainly due to foreign exchange, especially the stronger U.S. dollar affecting purchases, rather than inflation beyond the range already planned. The company also noted that average realized prices improved in both uranium and fuel services, and management reiterated that the annual production outlook was unchanged at 19.5 million to 21.5 million pounds of U3O8. She also explained Westinghouse revenue timing in broad terms, saying the first 5 years bring 50% of the revenue in the initial projects and that the model moves faster at end-of-a-kind, while the recurring core-business opportunity begins once plants enter operation.
Most of the Q&A focused on Westinghouse: the DOE’s $17.5 billion conditional commitment for AP1000 long-lead items, the separate Department of Commerce strategic partnership, the 91-reactor AP1000 pipeline, and how backlog and project economics should be interpreted. Management said the next step for the DOE process is definitive agreements with specific U.S. utilities and the DOE, but they repeatedly said they could not discuss IPO timing or other SEC-restricted matters. They also explained that DOE and Commerce are separate tracks for now, that AP1000 costs are based on a pragmatic range, and that Westinghouse’s long-lead-item SPVs use equity in the form of margin rather than cash from Westinghouse for these structures.
The company said nuclear demand support is broadening, uranium pricing is strong, and Cameco is benefiting from a tightening supply-demand backdrop without yet seeing replacement-rate contracting. Management highlighted more than 28 million pounds per year of contracted average annual deliveries over the next 5 years, unchanged production guidance, and strong realized pricing trends. Westinghouse’s AP1000 pipeline, DOE financing support, and the company’s strategic position across the nuclear fuel cycle all suggest multiple growth drivers beyond the quarter.
The quarter was weaker than last year because of a large Westinghouse-related payment in 2025, and Cameco also faced operational disruption from spring road conditions and a temporary Cigar Lake suspension after quarter-end. Management said some outlook metrics changed because of foreign exchange, and the business remains exposed to delivery timing, product mix, and customer scheduling variability. On Westinghouse, many of the growth disclosures are still conditional, with management declining to discuss IPO timing, definitive agreement timing, and specific probability estimates for the 91-reactor pipeline.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.8%
- Shares Outstanding
- 435.53M
- Float Shares
- 434.48M
of shares held by institutions
1,102 13F filers
Congressional trading
Senate and House stock disclosures for CCJ, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Gilbert Ray CisnerosHouse · CA31 | Sell | Jan 9, 26 | Filing → |
| Gilbert Ray CisnerosHouse · CA31 | Sell | Dec 24, 25 | Filing → |
| Gilbert Ray CisnerosHouse · CA31 | Buy | Nov 18, 25 | Filing → |
| Gilbert Ray CisnerosHouse · CA31 | Buy | Oct 17, 25 | Filing → |
| Thomas Hawley TubervilleSenate · AL | Buy | May 7, 24 | Filing → |
| Thomas Hawley TubervilleSenate · AL | Sell | Apr 3, 24 | Filing → |
| Lamar Seeligson SmithHouse · TX21 | Buy | Oct 8, 18 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 18.06M | ▲ 258.19K |
| Mirae Asset Global Etfs Holdings Ltd. | 15.55M | ▲ 176.86K |
| Capital World Investors | 13.37M | ▲ 102.19K |
| Vanguard Capital Management LLC | 12.02M | ▲ 154.47K |
| Royal Bank Of Canada | 10.91M | ▲ 1.31M |
| Fil Ltd | 8.43M | ▼ 460.35K |
| Fmr LLC | 7.98M | ▼ 1.26M |
| Van Eck Associates Corp | 7.54M | ▲ 596.93K |
| Bank Of Montreal /Can/ | 7.36M | ▲ 1.35M |
| Bank Of America Corp | 7.22M | ▼ 176.92K |
| Morgan Stanley | 5.21M | ▲ 595.62K |
| Norges Bank | 5.11M | ▲ 5.11M |
Held by 82 ETFs
Biggest fund positions in CCJ by dollar value.
Our CCJ coverage
Recent articles, reports, and earnings notes.

newcleo plc IPO: What Investors Need to Know
newcleo plc Ordinary Shares is expected to list on NASDAQ on 2026-09-22, with the price range not yet disclosed. The deal is being pursued through a SPAC business combination with NewHold Investment Corp III under ticker NWCL. The setup favors investors who want exposure to advanced nuclear and fuel-cycle optionality, but the key watch item is whether the company can convert a long-dated technology story into a credible public-market path.

Inside the Holtec Nuclear Corp IPO: Risks, Setup, and Watchpoints
Holtec Nuclear Corp is expected to list on NASDAQ on 2026-09-18, with shares priced at $15.00 to $18.00. The company is offering 50,000,000 shares and has disclosed a market cap of $1.035 billion. The bull case is a long-established nuclear services platform with SMR optionality; the bear case is a complex structure, heavy debt, and a valuation that depends on execution.

Trump’s 50-Year Super Deal, Revealed: Every Stock Addison Wiggin Is Teasing in The Grey Swan
Addison Wiggin of Grey Swan Investment Fraternity is pitching “Trump’s 50-Year Super Deal.” We identify the three stocks and test its AI claims.
Want a deeper read on CCJ?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
New Strong Sell Stocks for October 6th
zacks.com · Oct 6
Cameco Stock Down to Below $90 -- Is Now the Time to Buy?
fool.com · Oct 5
Devon Energy (NYSE:DVN) & Cameco (NYSE:CCJ) Critical Contrast
defenseworld.net · Oct 5
Cameco Trades Near $85. Here's Why the Uranium Giant Might Be the Safest Way to Play the Nuclear Comeback
fool.com · Oct 4
Here's What a $10,000 Investment in Cameco 5 Years Ago Is Worth Today -- and What the Next 5 Years Could Look Like
fool.com · Oct 3
Uranium Prices Just Broke a 19-Year Record, but Nuclear Stocks Are Collapsing Anyway
247wallst.com · Oct 3
Cameco to Gain as Korea-U.S. Framework Supports Westinghouse
zacks.com · Oct 2
Forget URA's Concentration. This Nuclear Fund Spreads the Bet Across Utilities, Miners and Reactor Builders
247wallst.com · Oct 1
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed October 2, 2026 · Live quote · Not investment advice